Number of patients: 654
Follow up: 6, 12 and 24- month
Type of lesion: Non-selected, real world population
Clinical events occurred in RANGO registry were very low at 12-months FU. The TLF represent a very low rate showing high efficacy, and ST of 0.61% showed a safety profile comparable with DES current in the market.
Dr A. Pérez de Prado, Hospital and University of León (León, SPA)